Patents by Inventor Johannes Aufenanger

Johannes Aufenanger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5385828
    Abstract: The invention refers to a method for determining the relative amounts of all cholesterol-containing lipoproteins in body fluids comprising electrophoretically separating the lipoproteins of an aliquot of body fluid on a thin layer carrier matrix, incubating the carrier matrix, containing the separated lipoproteins with cholesterol esterase and cholesterol dehydrogenase, forming a provable complex, and determining the relative amounts of the different lipoprotein classes2. The new method makes it possible to simultaneously determine HDL-, LDL-, VLDL- and LP (X)-cholesterol in body fluids with a high accuracy even at small concentrations. The thin layer matrices obtained electrophoretically, are very easy to handle and to record.
    Type: Grant
    Filed: November 24, 1992
    Date of Patent: January 31, 1995
    Assignee: "Immuno" Aktiengesellschaft fur chemisch-medizinische Produkte
    Inventor: Johannes Aufenanger
  • Patent number: 5192806
    Abstract: The present invention is concerned with the use of TXA.sub.2 receptor antagonists for the preparation of pharmaceutical compositions for the prevention of degenerative changes in penile tissue.
    Type: Grant
    Filed: April 15, 1991
    Date of Patent: March 9, 1993
    Assignee: Boehringer Mannheim GmbH
    Inventors: Johannes Pill, Johannes Aufenanger, Thomas Konrad, Klaus-Peter Junemann